Literature DB >> 7361804

Seizures associated with high cerebrospinal fluid concentrations of cefazolin.

T P Bechtel, R L Slaughter, T D Moore.   

Abstract

Three cases of generalized seizures in patients with high cerebrospinal fluid (CSF) concentrations of cefazolin are reported. Patient 1, a 60-year-old woman with impaired renal function and a Klebsiella pneumoniae infection, was treated with 70 mg every eight hours of i.v. gentamicin sulfate and 1.5 g every four hours of i.v. cefazolin sodium. Gentamicin was discontinued on day 11. On day 12, the patient had a generalized tonic-clonic seizure. Serum and CSF concentrations of cefazolin one day later were 470 and 64 micrograms/ml, respectively. Patient 2, a 70-year-old man with impaired renal function, was given i.v. cefazolin, 1 g every 12 hours; the dosage interval was shortened later to every six hours. Two days later, the patient had two tonic-clonic seizures. Serum and CSF concentrations eight hours after the last dose of cefazolin were 360 and 34 micrograms/ml, respectively. Patient 3, a 67-year-old woman with renal vein thrombosis, received 55 mg every eight hours of i.v. gentamicin and 2 g every six hours of i.v. cefazolin. The antibiotics were discontinued after eight days when the patient had two tonic-clonic seizures. Serum and CSF concentrations of cefazolin measured 28 hours later were 1000 and 106 micrograms/ml, respectively. Previous reports of cefazolin-associated seizures are reviewed. In patients with renal failure, cefazolin may obtain high CSF concentrations. To avoid seizures, cefazolin doses should be adjusted in these patients.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7361804

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  12 in total

Review 1.  [Central nervous system side effects of different antibacterial substances].

Authors:  G Stoppe; E Rüther
Journal:  Infection       Date:  1991       Impact factor: 3.553

Review 2.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

3.  Animal model for evaluating the convulsive liability of beta-lactam antibiotics.

Authors:  P D Williams; D B Bennett; C R Comereski
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

4.  High-Dosage Cefazolin Achieves Sufficient Cerebrospinal Diffusion To Treat an External Ventricular Drainage-Related Staphylococcus aureus Ventriculitis.

Authors:  Matthieu Grégoire; Benjamin Gaborit; Colin Deschanvres; Raphaël Lecomte; Guillaume Deslandes; Éric Dailly; Xavier Ambrosi; Ronan Bellouard; Nathalie Asseray; Karim Lakhal; David Boutoille
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

5.  Focal motor status epilepticus following treatment with azlocillin and cefotaxime.

Authors:  S J Wroe; J E Ellershaw; J A Whittaker; A Richens
Journal:  Med Toxicol       Date:  1987 May-Jun

Review 6.  Side effects of cephalosporins.

Authors:  S R Norrby
Journal:  Drugs       Date:  1987       Impact factor: 9.546

7.  Inhibitory effect of cephalosporins on gamma-aminobutyric acid receptor binding in rat synaptic membranes.

Authors:  S Hori; S Kurioka; M Matsuda; J Shimada
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 8.  Drug-induced seizures in the elderly. Causative agents and optimal management.

Authors:  K L Franson; D P Hay; V Neppe; W Y Dahdal; W U Mirza; G T Grossberg; D M Chatel; P A Szwabo; S Kotegal
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

9.  Low neurotoxicity of LJC 10,627, a novel 1 beta-methyl carbapenem antibiotic: inhibition of gamma-aminobutyric acidA, benzodiazepine, and glycine receptor binding in relation to lack of central nervous system toxicity in rats.

Authors:  M Hikida; Y Masukawa; K Nishiki; N Inomata
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

10.  Effect of experimental renal failure and hypotonic hyponatremia on the pharmacodynamics of cefazolin-induced seizures in rats.

Authors:  Masashi Nagata; Takuya Fujichika; Masato Yasuhara
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.